Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Super Session: Honoring Dr. Stelios Papadopoulos, Chair of the Board, Exelixis with the Distinguished Service Award (5th award in 19 years).
8:15 AM – 8:45 AM
Registration and Networking
8:45 AM – 8:55 AM
Welcome address: Karun Rishi, President, USAIC
Opening comments: Dr Andrew Plump, President of Research & Development, Takeda
8:55 AM – 9:40 AM
Panel: BioPharma- Measures for Unpredictable Times
Panelists:
Christopher Viehbacher, President & CEO, Biogen
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
Dr. Susan Hockfield, President Emerita, Massachusetts Institute of Technology (MIT)
Moderator:
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
9:40 AM – 10:25 AM
Panel: Rare & Neuro Diseases
Panelists:
Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics
Dr. Fiona Elwood, Vice President, Neurodegeneration DAS, J&J Innovative Medicine
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Dr. Nancy Andrews, Executive Vice President & CSO, Boston Children’s Hospital
Dr. Zandy Forbes, President & CEO, MeiraGTx
Moderator:
Dr. Steve Uden, Co-Founder & CEO, Rallybio
10:25 AM – 10:55 AM
Networking Break
10:55 AM – 11:40 AM
Panel: BioPharma Investment Priorities
Panelists:
Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Kris Jenner, Co-Founder & Managing Member, Rock Springs Capital
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Senior Managing Partner, F-Prime Capital
Moderator:
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc.
11:40 AM – 12:25 PM
Panel: Clinical Trials Opportunities in India
Panelists:
Badhri Srinivasan, Executive Chairman, Unilabs
Dr. Christoph Koenen, Head of Clinical Development & Operations, Pharma R&D, Bayer
Dinkar Saran, Partner- Pharma and Life Sciences Operations, PwC
Peyton Howell, Chief Executive Officer, Parexel
Dr. Sarah Sheikh, Head of Global Development, Takeda
Moderator:
Peter Ronco, Chief Executive Officer, Emmes
12:25 PM – 1:25 PM
Lunch
1:25 PM – 2:10 PM
Panel: Oncology
Panelists:
Dr. Michael Morrissey, President & CEO, Exelixis
Dr. Paul-Peter Tak, President & CEO, Candel Therapeutics
Dr. Steve Harr, President & CEO, Sana Biotechnology
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Dr. Toni Choueiri, Director, Genitourinary (GU) Oncology, Dana-Farber Cancer Institute
Moderator:
Dr. Najat Khan, Chief R&D and Commercial Officer, Recursion
2:10 PM – 2:55 PM
Panel: R&D strategies in an era of unprecedented uncertainty and opportunity
Panelists:
Dr. Andrew Plump, President of Research & Development, Takeda
Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Maria Freire, Principal, The Freire Group
Dr. Mathai Mammen, Chairman & CEO, Parabilis Medicines
Moderator:
Dr. Kush Parmar, Managing Partner, 5AM Ventures
2:55 PM – 3:25 PM
Networking Break
3:25 PM – 4:10 PM
Panel: Digital & Data Science in Healthcare
Panelists:
Dr. Belen Fraile, Chief R&D Data Science Officer, Johnson & Johnson Innovative Medicine
Dr. Dina Katabi, Professor of Computer Science, Massachusetts Institute of Technology (MIT)
Dr. Nicole Glazer, Senior Vice President R&D Data, Takeda
Parag Saxena, Co-Founder & Managing Partner, Vedanta Capital
Dr. Paul Burton, Chief Medical Officer, Amgen
Moderator:
Sastry Chilukuri, Chairman & CEO, Emmes Group
4:10 PM – 4:15 PM
Closing Remarks: Dr Andrew Plump, President of Research & Development, Takeda
4:15 PM – 4:50 PM
Honouring Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc. with the
Distinguished Service Award
Tributes by:
Dr. Maria Freire, Principal, The Freire Group
Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Paris Panayiotopoulos, Senior Managing Director, Blackstone Life Sciences
Christopher Viehbacher, President & CEO, Biogen
4:50 PM – 5:00 PM
BioPharma Sisterhood Group Photo
5:00 PM – 6:00 PM
Networking Reception
*Program and Speakers subject to change
Please keep your cell phone in silent mode
Click here to download a PDF of this agenda. 
